A phase I/II study of gemcitabine during radiotherapy in children with newly diagnosed diffuse intrinsic pontine glioma

The purpose of this phase I/II, open-label, single-arm trial is to investigate the safety, tolerability, maximum tolerated dose and preliminary efficacy of the potential radiosensitizer gemcitabine, administered concomitantly to radiotherapy, in children with newly diagnosed diffuse intrinsic pontin...

Descripción completa

Detalles Bibliográficos
Autores principales: Veldhuijzen van Zanten, Sophie E. M., El-Khouly, Fatma E., Jansen, Marc H. A., Bakker, Dewi P., Sanchez Aliaga, Esther, Haasbeek, Cornelis J. A., Wolf, Nicole I., Zwaan, C. Michel, Vandertop, W. Peter, van Vuurden, Dannis G., Kaspers, Gertjan J. L.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer US 2017
Materias:
Clinical Study
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5663796/
https://www.ncbi.nlm.nih.gov/pubmed/28748343
http://dx.doi.org/10.1007/s11060-017-2575-9

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5663796/
https://www.ncbi.nlm.nih.gov/pubmed/28748343
http://dx.doi.org/10.1007/s11060-017-2575-9

Ejemplares similares